BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhang L, Liang B, Xu H, Gong Y, Hu W, Jin Z, Wu X, Chen X, Li M, Shi L, Shi Y, Wang Y, Yang L. Cinobufagin induces FOXO1-regulated apoptosis, proliferation, migration, and invasion by inhibiting G9a in non-small-cell lung cancer A549 cells. J Ethnopharmacol 2022;:115095. [PMID: 35176466 DOI: 10.1016/j.jep.2022.115095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun M, Huang D, Liu Y, Chen H, Yu H, Zhang G, Chen Q, Chen H, Zhang J. Effects of Cinobufagin on the Proliferation, Migration, and Invasion of H1299 Lung Cancer Cells. Chem Biodivers 2023;20:e202200961. [PMID: 36522286 DOI: 10.1002/cbdv.202200961] [Reference Citation Analysis]
2 Wang C, Mei X, Wu Y, Yang Y, Zeng Z. Cinobufagin alleviates lipopolysaccharide-induced acute lung injury by regulating autophagy through activation of the p53/mTOR pathway. Front Pharmacol 2022;13. [DOI: 10.3389/fphar.2022.994625] [Reference Citation Analysis]
3 Liang P, Ma Y, Yang L, Mao L, Sun Q, Sun C, Liu Z, Mazhar M, Yang S, Ren W. Uncovering the Mechanisms of Active Components from Toad Venom against Hepatocellular Carcinoma Using Untargeted Metabolomics. Molecules 2022;27. [PMID: 36431859 DOI: 10.3390/molecules27227758] [Reference Citation Analysis]
4 Qin YY, Feng S, Zhang XD, Peng B. Screening of traditional Chinese medicine monomers as ribonucleotide reductase M2 inhibitors for tumor treatment. World J Clin Cases 2022; 10(31): 11299-11312 [DOI: 10.12998/wjcc.v10.i31.11299] [Reference Citation Analysis]
5 Chen H, Zheng M, Zhang W, Long Y, Xu Y, Yuan M. Research Status of Mouse Models for Non-Small-Cell Lung Cancer (NSCLC) and Antitumor Therapy of Traditional Chinese Medicine (TCM) in Mouse Models. Evidence-Based Complementary and Alternative Medicine 2022;2022:1-13. [DOI: 10.1155/2022/6404853] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]